Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Caffeine Therapy for Oral Feeding in Preterm Infants
NCT06327152Phase 2Active, not recruiting
- Sponsor
- University of California, Irvine
- Start
- Feb 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of caffeine in apnea of prematurity (AOP), sponsored by University of California, Irvine. Started Feb 2024; status: active, not recruiting.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on NCT06327152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06327152.